2011-01-20 17:16:03 UTC

NQF Endorses Measures for Endoscopy/Polyp Surveillance

Jan. 20, 2011

The National Quality Forum endorsed two measures related to appropriate follow-up intervals and recommendations based on history/previous findings.

In 2008, AGA, ASGE and ACG, along with the AMA-convened Physician Consortium for Performance  Improvement®, developed three measures regarding colonoscopy and polyp surveillance. One of these measures (colonoscopy interval for patients with a history of adenomatous polyps — avoidance of inappropriate use) has been incorporated by CMS into physician quality reporting as measure number 185.

In 2010, all three measures were submitted to the National Quality Forum (NQF) for endorsement. This week, the NQF announced that two of the endoscopy/polyp surveillance measures (appropriate follow-up interval for normal colonoscopy in average-risk patients and colonoscopy interval for patients for history of adenomatous polyps — avoidance of inappropriate use) have received time-limited endorsement. Both measures are related to appropriate follow-up intervals/recommendations based on history/previous findings. The NQF has declined to endorse the comprehensive colonoscopy documentation measure.

While NQF endorsement is not a requirement for CMS or a commercial payor to include a measure in their quality reporting system, lack of endorsement implies that the NQF did not establish that reporting the comprehensive colonoscopy documentation measure would lead to an improvement in health outcomes.

More on Colorectal Cancer

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

Advocate CMS, close the colonoscopy loophole

March 8, 2018

AGA urges CMS to address the cost sharing problem that arises when screening colonoscopies become diagnostic for Medicare patients.